CCXI - ChemoCentryx GAAP EPS of -$0.58 in-line revenue of $2.32M misses by $1.58M March, 01 2022 04:19 PM ChemoCentryx Inc. ChemoCentryx press release (NASDAQ:CCXI): Q4 GAAP EPS of -$0.58 in-line. Revenue of $2.32M (-46.8% Y/Y) misses by $1.58M. Shares -14.6%. For further details see: ChemoCentryx GAAP EPS of -$0.58 in-line, revenue of $2.32M misses by $1.58M